Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: an open-label, multi-center, non-comparative phase II study
Authors
Keywords
Advanced breast cancer, Pegylated liposomal doxorubicin, Metastatic breast cancer, Taxane failure, Safety
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-21
DOI
10.1186/s12885-015-1433-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG
- (2014) C. H. Smorenburg et al. ANNALS OF ONCOLOGY
- Pegylated Liposomal Doxorubicin (Caelyx®) and Oral Vinorelbine in First-Line Metastatic Breast Cancer Patients Previously Treated with Anthracyclines
- (2014) L. Livi et al. JOURNAL OF CHEMOTHERAPY
- Continuing routine cardiac surveillance in long-term use of pegylated liposomal doxorubicin: Is it necessary?
- (2013) Sarah E. Gill et al. GYNECOLOGIC ONCOLOGY
- Global cancer patterns: causes and prevention
- (2013) Paolo Vineis et al. LANCET
- Current approaches and future directions in the treatment of HER2-positive breast cancer
- (2012) Sara A. Hurvitz et al. CANCER TREATMENT REVIEWS
- The development of endocrine therapy for women with breast cancer
- (2012) Richard Sainsbury CANCER TREATMENT REVIEWS
- Phase II Trial of Pegylated Liposomal Doxorubicin in Combination With Gemcitabine in Metastatic Breast Cancer Patients
- (2011) Jean-Philippe Jacquin et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial
- (2011) D. Rayson et al. ANNALS OF ONCOLOGY
- Pegylated liposomal doxorubicin in combination with cyclophosphamide and trastuzumab in HER2-positive metastatic breast cancer patients: efficacy and cardiac safety from the GEICAM/2004-05 study
- (2011) M. Martin et al. ANNALS OF ONCOLOGY
- Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial
- (2011) Michael Fiegl et al. BMC CANCER
- Pegylated liposomal doxorubicin as first-line monotherapy in elderly women with locally advanced or metastatic breast cancer: Novel treatment predictive factors identified
- (2011) H. Green et al. CANCER LETTERS
- Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines
- (2011) E. Curtit et al. EUROPEAN JOURNAL OF CANCER
- Duration of Chemotherapy for Metastatic Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2011) Alessandra Gennari et al. JOURNAL OF CLINICAL ONCOLOGY
- A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study
- (2011) Patrizia Vici et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Maintenance treatment with Pegylated liposomal doxorubicin versus observation following induction chemotherapy for metastatic breast cancer: GEICAM 2001-01 study
- (2010) Emilio Alba et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase III Trials of Eribulin Mesylate (E7389) in Extensively Pretreated Patients With Locally Recurrent or Metastatic Breast Cancer
- (2010) Chris Twelves et al. Clinical Breast Cancer
- Weekly Paclitaxel Combining with Gemcitabine is an Effective and Safe Treatment for Advanced Breast Cancer Patients
- (2010) K.-M. Rau et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Single-agent treatment with pegylated liposomal doxorubicin for metastatic breast cancer
- (2009) Mary E.R. OʼBrien ANTI-CANCER DRUGS
- Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
- (2009) R.C.F. Leonard et al. BREAST
- Capecitabine and vinorelbine in metastatic breast cancer
- (2009) Arlene Chan et al. EUROPEAN JOURNAL OF CANCER
- Pegylated Liposomal Doxorubicin Plus Docetaxel Significantly Improves Time to Progression Without Additive Cardiotoxicity Compared With Docetaxel Monotherapy in Patients With Advanced Breast Cancer Previously Treated With Neoadjuvant-Adjuvant Anthracycline Therapy: Results From a Randomized Phase III Study
- (2009) Joseph A. Sparano et al. JOURNAL OF CLINICAL ONCOLOGY
- Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
- (2008) Eva S. Thomas JOURNAL OF CLINICAL ONCOLOGY
- Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer
- (2008) Martine J. Piccart-Gebhart et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search